Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 4.07Vadivarhe Speciality Chemicals Ltd, a company in the chemical and petrochemicals sector, exhibits a mixed financial performance. The company shows very strong solvency, suggesting it relies primarily on equity rather than debt for funding. However, its liquidity, growth, coverage, and profitability all appear weak, indicating potential challenges in meeting short-term obligations, expanding operations, and generating profit. On the positive side, the company's capital expenditures are well-managed. Areas of concern include negative interest coverage and inconsistent earnings, which could pose risks for investors. Overall, the company's financial health requires close monitoring due to its volatile performance and areas of significant weakness, despite its strong solvency position.
Health Score : 4.07Vadivarhe Speciality Chemicals Ltd, a company in the chemical and petrochemicals sector, exhibits a mixed financial performance. The company shows very strong solvency, suggesting it relies primarily on equity rather than debt for funding. However, its liquidity, growth, coverage, and profitability all appear weak, indicating potential challenges in meeting short-term obligations, expanding operations, and generating profit. On the positive side, the company's capital expenditures are well-managed. Areas of concern include negative interest coverage and inconsistent earnings, which could pose risks for investors. Overall, the company's financial health requires close monitoring due to its volatile performance and areas of significant weakness, despite its strong solvency position.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-3.15
Industry Median
37.33
Small Cap Median
36.44
P/E RATIO
-3.15
P/B RATIO
-4.40
Industry Median
2.54
Small Cap Median
2.32
P/S RATIO
0.77
Industry Median
2.39
Small Cap Median
1.89
Others
PEG RATIO
-2.07
EV/EBITDA RATIO
-8.56
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹22.85 as on Aug 11, 2026.
Growth Score : 2.00All growth metrics, including revenue growth, operating profit growth, EPS growth, asset growth, and net income growth, are at very low levels. This indicates significant challenges in expanding operations and increasing profitability. The company needs to identify and address the factors hindering its growth to ensure long-term sustainability. Without growth, the company may struggle to remain competitive in the market.
Revenue Growth RatePoorOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoorNet Income Growth RatePoor| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | -7.38 | -18.96 | 103.64 | -8.24 | -5.41 |
| Operating Profit Growth Rate | -94.16 | 1157.41 | -150.96 | 32.95 | -228.04 |
| Earnings Per Share (EPS) Growth | -71.95 | 248.15 | -111.97 | -94.44 | -14600 |
| Asset Growth Rate | -11.68 | 11.45 | -10.4 | 2.69 | |
| Net Income Growth Rate | -71.95 | 248.19 | -111.97 | -94.78 | -15550 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Saroja Pharma Industries India Ltd | 7.47 | 13.67 | Neutral | 3.81 | 4.02 | 1.62 |
| 2 | Sanginita Chemicals Ltd | 7.17 | 62.58 | Undervalued | -6.00 | -3.74 | -10.00 |
| 3 | Yasons Chemex Care Ltd | 5.91 | 19.08 | Neutral | -0.59 | 0.49 | 0.94 |
| 4 | Vadivarhe Speciality Chemicals Ltd | 4.07 | -3.15 | Highly Undervalued | -6.42 | -7.25 | -9.27 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Vadivarhe Speciality Chemicals Ltd (VSCL) is an India-based company primarily engaged in the manufacturing and trading of specialty chemicals. It serves diverse industrial sectors, including pharmaceuticals, agrochemicals, and other fine chemical applications, focusing on custom synthesis and chemical intermediates.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Vadivarhe Speciality Chemicals Ltd's P/E ratio (TTM) is -3.15, compared to the industry median of 37.33 and large cap median of 36.44.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Vadivarhe Speciality Chemicals Ltd's P/B ratio is -4.40, compared to the industry median of 2.54 and large cap median of 2.32.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Vadivarhe Speciality Chemicals Ltd's P/S ratio is 0.77, compared to the industry median of 2.39 and large cap median of 1.89.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Vadivarhe Speciality Chemicals Ltd's PEG ratio is -2.07.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Vadivarhe Speciality Chemicals Ltd's EV/EBITDA ratio is -8.56.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Vadivarhe Speciality Chemicals Ltd's ROE is N/A.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Vadivarhe Speciality Chemicals Ltd's ROA is -13.78%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Vadivarhe Speciality Chemicals Ltd's ROCE is -22.66%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Vadivarhe Speciality Chemicals Ltd's operating margin is -15.54%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Vadivarhe Speciality Chemicals Ltd's net margin is -24.45%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Vadivarhe Speciality Chemicals Ltd's current ratio is 0.89.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Vadivarhe Speciality Chemicals Ltd's debt-to-equity ratio is -8.14.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Vadivarhe Speciality Chemicals Ltd's interest coverage ratio is -4.39.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Vadivarhe Speciality Chemicals Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Vadivarhe Speciality Chemicals Ltd's EPS is -14600.
(Source line: "Ratios as of 11 Aug 2026, based on last traded price of ₹22.85. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Incorporated in 1989 as Vadivarhe Chemicals Ltd., the company focused on manufacturing various chemical products. In 2011, it changed its name to Vadivarhe Speciality Chemicals Ltd., reflecting its emphasis on higher-value specialty chemicals. Over the years, VSCL has expanded its product portfolio and strengthened its position in the Indian chemical industry.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Specialty Chemicals & Intermediates | 100% | N/A (Segment-specific EBITDA not disclosed) |
Ashok N. Agarwal - Chairman & Managing Director: A seasoned professional with extensive experience in the chemical manufacturing industry, he provides strategic leadership to the company.
No major subsidiaries reported.
Notable corporate actions include a stock split from face value ₹10 to ₹1 (1:10) effective August 24, 2023. No major recent bonus issues, rights issues, or M&A on record.
References
The Vadivarhe Speciality Chemicals Ltd share price today is ₹22.85 on NSE (VSCL), as of 12 Aug 2026.
As of 11 Aug 2026, Vadivarhe Speciality Chemicals Ltd share price is ₹22.85, with previous close ₹N/A. Today's range is ₹N/A to ₹N/A. The 52-week range is ₹N/A to ₹N/A.
As of today, Vadivarhe Speciality Chemicals Ltd's market cap is ₹29.25 crore (Small Cap).
Vadivarhe Speciality Chemicals Ltd's current P/E ratio is -3.15, compared to the CHEMICALS & PETROCHEMICALS sector average of 35.
Vadivarhe Speciality Chemicals Ltd's current P/B ratio is -4.40.
Vadivarhe Speciality Chemicals Ltd's current dividend yield is N/A. Last dividend of ₹0.05 per share was declared on 12-Aug-2023.
Vadivarhe Speciality Chemicals Ltd's EPS (TTM) is ₹-14600.
Vadivarhe Speciality Chemicals Ltd (VSCL) is an India-based company primarily engaged in the manufacturing and trading of specialty chemicals. It serves diverse industrial sectors, including pharmaceuticals, agrochemicals, and other fine chemical applications, focusing on custom synthesis and chemical intermediates.
Vadivarhe Speciality Chemicals Ltd is promoted by Ashok N. Agarwal / Agarwal Group, holding 26.18% as of 11 Aug 2026.
Vadivarhe Speciality Chemicals Ltd is listed on NSE (VSCL) and BSE ({bse}). Its next quarterly results are expected on May/June 2024 (Q4 FY24).
Cash Earnings Per Share (Cash EPS)
Financial Health & Prudence